Back

Standard-of-care combination treatment rescues GFR decline and cardiac damage in a novel cardiovascular-kidney-metabolic syndrome mouse model with chronic kidney disease and HFpEF

12 April 2024 (08:30 - 14:00)
Organised by: Logo
Congress Presentation Part of: Late-breaking science poster session Lipid Metabolism, Metabolic Syndrome, Diabetes CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Arianne Van Koppen

TNO Research, Den Haag (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
LncRNAs in response to endoplasmic reticulum stress: novel players in abdominal aorta aneurysm pathophysiology.
Mr R. Almendra-Pegueros (Barcelona, ES)
Presentation thumbnail
Exploring the therapeutic potential of cannabidiol and its carboxylic acid in low-grade inflammation and atherosclerosis progression
Associate Professor M. Maly (Prague, CZ)
Presentation thumbnail
Cold storage of ultrathin cardiac slices to preserve the native electrophysiological response to physiological stimuli
Miss C. Lopez Andres (Zaragoza, ES)
Presentation thumbnail
miR-652-3p as potential biomarker in the early diagnosis of chemotherapy-induced cardiotoxicity
Ms M. Vilar Sanchez (Santiago de Compostela, ES)
Presentation thumbnail
The pro-atherogenic effects of CXCL5 haploinsufficiency
Ms R. Sanchez-Hodge (Chapel Hill, US)

Access the full session

Session thumbnail
Late-breaking science poster session

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources